Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1994:82:3-20.

Recombinant vector vaccines in vaccinology

M R Hilleman  1
Affiliations
  • PMID: 7958480
Review

Recombinant vector vaccines in vaccinology

M R Hilleman. Dev Biol Stand. 1994.

Abstract

The development of recombinant vector vaccines will be guided by nearly two centuries of research in vaccinology and immunology. Experimental vector vaccines may be of viral, bacterial or genetic composition and their acceptability will depend on safety, efficacy, and practicality as seen by the user, the developer, and the licensing authority. Recombinant vector vaccines will need to compete with alternative vaccine approaches and may find special use for non-propagable agents, immunization in early life, fertility control, and emerging infectious agents. Needs of the developing nations that include low cost, temperature stability, and ease of administration may be met, in part at least, by the vector vaccine approach.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

  • mRNA vaccine delivery using lipid nanoparticles.
    Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. Reichmuth AM, et al. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Ther Deliv. 2016. PMID: 27075952 Free PMC article. Review.
  • Developing mRNA-vaccine technologies.
    Schlake T, Thess A, Fotin-Mleczek M, Kallen KJ. Schlake T, et al. RNA Biol. 2012 Nov;9(11):1319-30. doi: 10.4161/rna.22269. Epub 2012 Oct 12. RNA Biol. 2012. PMID: 23064118 Free PMC article. Review.
  • An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.
    Nag K, Chandra Baray J, Rahman Khan M, Mahmud A, Islam J, Myti S, Ali R, Haq Sarker E, Kumar S, Hossain Chowdhury M, Roy R, Islam F, Barman U, Khan H, Chakraborty S, Badsha A, Hossain M, Ahammad S, Rahman Chowdhury M, Ghosh P, Islam Shimul R, Ahmmed R, Hussain Bhuiya E, Kumar Biswas B, Mohiuddin M, Sultana N. Nag K, et al. Vaccine. 2021 Jun 23;39(28):3745-3755. doi: 10.1016/j.vaccine.2021.05.035. Epub 2021 May 18. Vaccine. 2021. PMID: 34039497 Free PMC article.
  • Viral vectors for veterinary vaccines.
    Sheppard M. Sheppard M. Adv Vet Med. 1999;41:145-61. doi: 10.1016/s0065-3519(99)80014-7. Adv Vet Med. 1999. PMID: 9890015 Free PMC article. Review.
  • Applications of microfluidics in mRNA vaccine development: A review.
    Fardoost A, Karimi K, Govindaraju H, Jamali P, Javanmard M. Fardoost A, et al. Biomicrofluidics. 2024 Nov 14;18(6):061502. doi: 10.1063/5.0228447. eCollection 2024 Dec. Biomicrofluidics. 2024. PMID: 39553921 Review.

MeSH terms

LinkOut - more resources